Accumulating evidence pointing to mitochondria as critical participants in
the control of apoptotic and necrotic cell death and in the development of
specific disease states has led to a renaissance art the study of these org
anelles. Because mitochondria are the major consumers of molecular oxygen w
ithin cells, they stand as one of the most important generators of reactive
oxygen species and therefore constitute potential targets of therapeutic i
ntervention in pathologic states in which oxidative stress originates from
these organelles. In this regard, mitochondria are specific targets of etha
nol intoxication, thereby leading to reported morphologic and functional al
terations of mitochondria. Because mitochondria are also indispensable for
the maintenance of cell functions, their dysfunction induced by ethanol may
be a key event in the development of alcoholic liver disease. Indeed, chro
nic ethanol feeding in experimental animals has been reported to cause a se
lective deficiency in the availability of reduced glutathione (GSH) in, mit
ochondria due to the impaired functioning of the specific mitochondrial car
rier that translocates GSH from cytosol into the mitochondrial matrix. Such
a selective depletion sensitizes hepatocytes from chronic ethanol-fed anim
als to the oxidative effects of cytokines, e.g., tumor necrosis factor (TNF
). Restoration of mitochondrial GSH by the in vivo administration of S-aden
osyl-L-methionine or the in vitro use of GSH ethyl ester, prevents the susc
eptibility of hepatocytes to TNF. Although the nature of this specific carr
ier has not yet been uncovered, the elucidation of the mechanisms whereby e
thanol leads to its impaired activity may provide important clues as to its
function and mechanism of action, which in turn may be useful toward the d
efinitive characterization and identification of this important carrier.